Design, synthesis and medical evaluation of bioactive compounds and new materials
BICONMA
![Foto de Design, synthesis and medical evaluation of bioactive compounds and new materials](/img/grupo.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (2)
2024
-
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
Cell Reports Medicine, Vol. 5, Núm. 2
2021
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1